MedPath

Effects of Different Surgical Methods to Treat Obesity

Not Applicable
Completed
Conditions
Obesity
Type 2 Diabetes
Insulin Sensitivity
Registration Number
NCT01785134
Lead Sponsor
Karolinska Institutet
Brief Summary

Obese patients have an increased risk for developing severe metabolic disorders. This risk can only partly be reduced by weight reduction. The investigators have in a pilot study investigated if removal of abdominal fat (visceral) in addition to weight loss has additional beneficial effects on the metabolic profile and weight loss. This study aims to further investigate if removal of abdominal fat (major omentum) leads to beneficial metabolic effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
81
Inclusion Criteria

Body mass index over 40 kg/m2

Body mass index over 35 kg/m2 with obesity associated co-morbidities such as type 2 diabetes and/or additional cardiovascular risk factors -

Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Insulin Sensitivity at 2 Years2 years postoperative

Insulin sensitivity measured by hyperinsulinemic euglycemic clamp

Secondary Outcome Measures
NameTimeMethod
Body Composition at Two Years2 years postoperative
Blood Lipids2 years postoperative
Blood Pressure at 2 Years2 years postoperative
Body Mass Index at 2 Years2 years postoperative

Trial Locations

Locations (4)

Södertälje Hospital

🇸🇪

Södertälje, Stockholm, Sweden

Ersta Hospital

🇸🇪

Stockholm, Sweden

Karolinska University Hospital Huddinge

🇸🇪

Stockholm, Sweden

Danderyds Hospital

🇸🇪

Stockholm, Sweden

Södertälje Hospital
🇸🇪Södertälje, Stockholm, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.